The immune dysfunction in AD involves reduced innate immune cell activity at TLR sites, decreased IL-17 production, and impaired Treg cell function, all of which contribute to disease pathogenesis [100,101,102]. This evidence concerns the gene IL17A and Alzheimer disease.